Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :9461
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
Kenjiro Aogi,Kenichi Watanabe,Masahiro Kitada,Takashi Sangai,Shoichiro Ohtani,Tomoyuki Aruga,Hidetoshi Kawagichi,Tomomi Fujisawa,Shigeto Maeda,Takashi Morimoto,Nobuaki Sato,Shintaro Takao,Satoshi Morita,Norikazu Masuda,Masakazu Toi,Shinji Ohno
International Journal of Clinical Oncology.2021;26(7)1229
[DOI]
  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow